Abstract

Characterizing the functional overlap and mutagenic potential of different pathways of chromosomal double-strand break (DSB) repair is important to understand how mutations arise during cancer development and treatment. To this end, we have compared the role of individual factors in three different pathways of mammalian DSB repair: alternative-nonhomologous end joining (alt-NHEJ), single-strand annealing (SSA), and homology directed repair (HDR/GC). Considering early steps of repair, we found that the DSB end-processing factors KU and CtIP affect all three pathways similarly, in that repair is suppressed by KU and promoted by CtIP. In contrast, both KU and CtIP appear dispensable for the absolute level of total-NHEJ between two tandem I-SceI–induced DSBs. During later steps of repair, we find that while the annealing and processing factors RAD52 and ERCC1 are important to promote SSA, both HDR/GC and alt-NHEJ are significantly less dependent upon these factors. As well, while disruption of RAD51 causes a decrease in HDR/GC and an increase in SSA, inhibition of this factor did not affect alt-NHEJ. These results suggest that the regulation of DSB end-processing via KU/CtIP is a common step during alt-NHEJ, SSA, and HDR/GC. However, at later steps of repair, alt-NHEJ is a mechanistically distinct pathway of DSB repair, and thus may play a unique role in mutagenesis during cancer development and therapy.

Highlights

  • Faithful repair of DNA damage is essential to suppress genetic instability and tumorigenesis

  • We have developed assays to measure how these breaks are repaired, and how such repair can lead to mutations

  • We find that factors KU70/80 heterodimer (KU) and CtIP appear to affect the initial stages of repair of each of these pathways, regardless of the length of homology

Read more

Summary

Introduction

Faithful repair of DNA damage is essential to suppress genetic instability and tumorigenesis. Characterizing the factors and pathways of DSB repair is important to understand the process of mutagenesis during cancer development and treatment. Alt-NHEJ appears to be independent of the above factors, and often results in a deletion with microhomology at the repair junction [4,5,6,7,8,9,10,11,12]. Genetic rearrangements consistent with alt-NHEJ have been observed in chromosomal translocations associated with both spontaneous and therapy-related cancer [13], and in reversion mutations of BRCA2 following DNA damage caused by PARPinhibition [14]. Alt-NHEJ-derived mutations appear to be associated with cancer development and may result from some cancer therapeutics

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call